等待開盤 10-23 09:30:00 美东时间
-0.180
-2.07%
RxSight, Inc., an ophthalmic medical device company, will feature multiple Live Learning Sessions at Booth #2931 during the American Academy of Ophthalmology Annual Meeting (AAO 2025). The sessions, scheduled from October 18–20 in Orlando, FL, will highlight real-world insights and clinical advantages of the Light Adjustable Lens, emphasizing its adjustability and economic impact.rx sight
10-16 20:05
LOS ANGELES, Aug. 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) have opp...
08-15 00:00
RxSight, Inc., an ophthalmic medical device company specializing in customized vision solutions following cataract surgery, announced its participation in the upcoming Wells Fargo Healthcare Conference in Boston. The presentation by RxSight’s management is scheduled for Thursday, September 4, 2025, at 7:15 a.m. Pacific Time / 10:15 a.m. Eastern Time. A live and archived webcast will be available at https://www.globenewswire.com/Tracker?data=M2_wL...
08-14 20:05
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $22 to $11.
08-08 19:20
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Vertical Aerospace press release (NYSE:EVTL): 1H Net profit of £250M Outlook: Maintained industry-leading capital efficiency and after July’s successful fundraise of gross proceeds of $69 million (£50...
08-05 19:51
RxSight, Inc. announced the appointment of Raymond W. Cohen to its Board of Directors. Cohen, a seasoned medical technology executive with over four decades of experience, brings significant expertise in scaling successful companies. He co-founded and led Axonics, Inc., which achieved exceptional growth and was acquired by Boston Scientific for $3.7 billion. Cohen also recently led the sale of SoniVie, Ltd., to Boston Scientific for $600 million....
08-04 12:05
AES press release (NYSE:AES): Q2 Non-GAAP EPS of $0.51 beats by $0.11. Revenue of $2.86B (-2.7% Y/Y) misses by $150M. Net Loss of $150 million, compared to Net Income of $153 million in Q2 2024 Net Lo...
08-01 12:34
PHILADELPHIA, July 25, 2025 /PRNewswire/ -- Berger Montague PC, a national securities litigation law firm announces it is investigating potential securities fraud claims involving RxSight, I...
07-26 02:26